Hypogonadotrophic hypogonadism: Difference between revisions
No edit summary |
Iqra Qamar (talk | contribs) |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]] | {{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]] | ||
Line 21: | Line 21: | ||
*Low [[libido]] | *Low [[libido]] | ||
*[[Infertility]] | *[[Infertility]] | ||
== Differentiating hypogonadism from other diseases: == | |||
Hypogonadotropic [[hypogonadism]] should be differentiated from other diseases causing [[hypogonadism]] like features.<ref name="pmid9541295">{{cite journal |vauthors=Sato N, Sze G, Endo K |title=Hypophysitis: endocrinologic and dynamic MR findings |journal=AJNR Am J Neuroradiol |volume=19 |issue=3 |pages=439–44 |year=1998 |pmid=9541295 |doi= |url=}}</ref><ref name="pmid7758238">{{cite journal |vauthors=Powrie JK, Powell M, Ayers AB, Lowy C, Sönksen PH |title=Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature |journal=Clin. Endocrinol. (Oxf) |volume=42 |issue=3 |pages=315–22 |year=1995 |pmid=7758238 |doi= |url=}}</ref><ref name="pmid26262437">{{cite journal |vauthors=Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S |title=Diagnosis of Primary Hypophysitis in Germany |journal=J. Clin. Endocrinol. Metab. |volume=100 |issue=10 |pages=3841–9 |year=2015 |pmid=26262437 |doi=10.1210/jc.2015-2152 |url=}}</ref><ref name="pmid7629223">{{cite journal |vauthors=Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S |title=Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings |journal=J. Clin. Endocrinol. Metab. |volume=80 |issue=8 |pages=2302–11 |year=1995 |pmid=7629223 |doi=10.1210/jcem.80.8.7629223 |url=}}</ref><ref name="pmid8345854">{{cite journal |vauthors=Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H |title=Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus |journal=N. Engl. J. Med. |volume=329 |issue=10 |pages=683–9 |year=1993 |pmid=8345854 |doi=10.1056/NEJM199309023291002 |url=}}</ref><ref name="pmid21668725">{{cite journal |vauthors=Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS |title=Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman |journal=Emerg Med Australas |volume=23 |issue=3 |pages=372–5 |year=2011 |pmid=21668725 |doi=10.1111/j.1742-6723.2011.01425.x |url=}}</ref><ref name="pmid9747750">{{cite journal |vauthors=Dejager S, Gerber S, Foubert L, Turpin G |title=Sheehan's syndrome: differential diagnosis in the acute phase |journal=J. Intern. Med. |volume=244 |issue=3 |pages=261–6 |year=1998 |pmid=9747750 |doi= |url=}}</ref> | |||
<small> | |||
{| class="wikitable" | |||
! rowspan="3" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Diseases}} | |||
! rowspan="3" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Onset}} | |||
! colspan="5" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Manifestations}} | |||
! colspan="4" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Diagnosis}} | |||
|- | |||
! colspan="4" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|History and Symptoms}} | |||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Physical examination}} | |||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Laboratory findings}} | |||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Gold standard}} | |||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Imaging}} | |||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Other investigation findings}} | |||
|- | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Trumatic delivery}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Lactation failure}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Menstrual irregularities}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Other features}} | |||
|- | |||
![[Sheehan's syndrome]] | |||
|Acute | |||
|<nowiki>++</nowiki> | |||
| ++ | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
|Symptoms of: | |||
* [[Adrenal insufficiency]] | |||
* [[Hypothyroidism]] | |||
| | |||
* [[Breast tissue]] [[atrophy]] | |||
* Decreased [[axillary]] and [[pubic]] hair growth | |||
| | |||
* [[Pancytopenia]] | |||
* [[Eosinophilia]] | |||
* [[Hyponatremia]] | |||
* Low [[fasting plasma glucose]] | |||
* Decreased levels of [[anterior pituitary]] [[hormones]] in blood | |||
| | |||
* Clinical diagnosis | |||
* Most senitive test: Low baseline [[prolactin]] levels w/o response to [[Thyrotropin-releasing hormone|TRH]] | |||
|CT/MRI: | |||
* Sequential changes of pituitary enlargement followed by: | |||
* Shrinkage and [[necrosis]] leading to decreased sellar volume or [[empty sella]] | |||
| | |||
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | |||
|- | |||
![[Lymphocytic hypophysitis]] | |||
|Acute | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
| | |||
* Associated with [[autoimmune]] conditions | |||
* Generalized [[headache]] | |||
* Retro-orbital or Bitemporal [[pain]] | |||
* Mass lesion effect such as [[Visual field defect|visual field defects]] | |||
| | |||
* [[Diabetes insipidus|DI]] | |||
* [[Autoimmune]] [[thyroiditis]] | |||
| | |||
* Decreased pituitary hormones([[Gonadotropins]] most common) | |||
* [[Hyperprolactinemia]](40%) | |||
* [[Growth hormone|GH]] excess | |||
| | |||
* [[Pituitary gland|Pituitary]] [[biopsy]]: [[lymphocytic]] [[Infiltration (medical)|infiltration]] | |||
| | |||
* [[CT]] & [[MRI]]: Features of a [[Pituitary gland|pituitary]] [[mass]] | |||
* Diffuse and homogeneous contrast enhancement | |||
|[[Assay|Assays]] for: | |||
* Anti-TPO | |||
* Anti-Tg Ab | |||
|- | |||
![[Pituitary apoplexy]] | |||
|Acute | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>++</nowiki> | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
|Severe [[headache]] | |||
* [[Nausea and vomiting]] | |||
* Paralysis of eye muscles ([[diplopia]]) | |||
* Changes in vision | |||
| | |||
* [[Visual acuity]] defects | |||
* [[Cranial nerve palsies|CN palsies]] (nerves III, IV, V , and VI) | |||
| | |||
* Decreased levels of [[anterior]] pituitary hormones in blood. | |||
| | |||
* [[Magnetic resonance imaging|MRI]] | |||
| | |||
* [[CT]] scan without [[Contrast medium|contrast]]: Hemorrhag<nowiki/>e on [[CT]] presents as a hyperdense lesion | |||
* [[MRI]]: If inconclusive [[CT]] | |||
| | |||
[[Blood tests]] may be done to check: | |||
* [[PT]]/[[INR]] and [[aPTT]] | |||
* [[Pituitary gland|Pituitary]] [[hormonal]] assay | |||
|- | |||
![[Empty sella syndrome]] | |||
|Chronic | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
| | |||
* [[Erectile dysfunction]] | |||
* [[Headache]] | |||
* Low [[libido]] | |||
| | |||
* Signs of raised [[intracranial pressure]] may be present | |||
* [[Nipple discharge|Nipple]] discharge | |||
| | |||
* Decreased levels of pituitary hormones in blood. | |||
| | |||
* [[MRI]] | |||
| | |||
* [[Empty sella]] containing [[Cerebrospinal fluid|CSF]] | |||
| | |||
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | |||
|- | |||
![[Simmond's Disease|Simmonds' disease]]/[[Pituitary]] [[cachexia]] | |||
|Chronic | |||
|<nowiki>+/-</nowiki> | |||
| + | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
| | |||
* [[Cachexia]] | |||
* [[Premature aging|Premature]] aging | |||
| | |||
* Progressive [[emaciation]] | |||
* Loss of body hair | |||
| | |||
* Decreased levels of anterior pituitary hormones in blood. | |||
| | |||
* [[Magnetic resonance imaging|MRI]] | |||
| | |||
* Done to rule out any pituitary cause | |||
| | |||
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | |||
|- | |||
! [[Primary hypothyroidism|Hypothyroidism]] | |||
|Chronic | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|[[Oligomenorrhea]]/[[menorrhagia]] | |||
| | |||
* Cold intolerance | |||
* [[Constipation]] | |||
| | |||
* Dry skin | |||
* [[Bradycardia]] | |||
* Hair loss | |||
* [[Myxedema]] | |||
* Delayed relaxation phase of deep [[Tendon reflex|tendon reflexes]] | |||
| | |||
* Low [[T3]],[[T4]] | |||
* Normal/ low [[Thyroid-stimulating hormone|TSH]] | |||
* Rest of pituitary hormone levels WNL | |||
| | |||
* [[TSH]] levels | |||
| | |||
* Done to rule out any pituitary cause | |||
| | |||
*Assays for anti-TPO and anti-Tg Ab | |||
*FNA biopsy | |||
|- | |||
![[Hypogonadotropic hypogonadism]] | |||
|Chronic | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
| | |||
* [[Hot flushes]] | |||
* Energy and mood changes | |||
* Decreased [[libido]] | |||
| | |||
* [[Breast tissue]] [[atrophy]] | |||
* Decreased [[maturation]] of [[vaginal]] [[mucosa]] | |||
| | |||
* Low [[estrogen]], [[testosterone]] | |||
* High [[FSH]]/[[Luteinizing hormone|LH]] | |||
| | |||
* [[FSH]] | |||
* [[Luteinizing hormone|LH]] | |||
| | |||
* Done to rule out any pituitary cause | |||
| | |||
* Genetic tests ([[karyotype]]) | |||
* Measurement of total and free [[testosterone]] and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] concentrations | |||
|- | |||
!Hypoprolactinemia | |||
|Chronic | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | |||
* [[Infertility]] | |||
* Subfertiliy | |||
| | |||
* Puerperal agalactogenesis | |||
| | |||
* No workup is necessary | |||
| | |||
* Decreased prolactin levels | |||
| | |||
* Done to rule out any pituitary cause | |||
| | |||
* [[Prolactin]] assay in [[3rd trimester]] | |||
* [[Luteinizing hormone|LH]], [[Follicle-stimulating hormone|FSH]] | |||
* [[Thyrotropin]] and free [[thyroxine]] | |||
|- | |||
![[Panhypopituitarism]] | |||
|Chronic | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
| | |||
* [[Polyuria]] | |||
* [[Polydipsia]] | |||
* Features of [[hypothyroidism]] and [[hypoadrenalism]] | |||
| | |||
* [[Growth failure]] | |||
* B/L [[hemianopsia]] | |||
* [[Papilledema]] | |||
| | |||
* All pituitary hormones decreased | |||
| | |||
* [[Magnetic resonance imaging|MRI]] | |||
| | |||
* Done to rule out any pituitary cause | |||
| | |||
* Left hand and wrist [[radiograph]] for [[bone age]] | |||
|- | |||
![[Primary adrenal insufficiency]]/[[Addison's disease]] | |||
|Chronic | |||
|<nowiki>-</nowiki> | |||
| - | |||
|<nowiki>-</nowiki> | |||
| | |||
* [[Hypoglycemia]] | |||
* [[Hypotension]] | |||
| | |||
* [[Dehydration]] | |||
* [[Hyperpigmentation]] | |||
* loss of [[pubic]] and [[axillary]] hair | |||
| | |||
* [[Hyponatremia]] with/without [[hyperkalemia]] | |||
* [[Plasma renin activity]] to [[Aldosterone|aldosterone ratio]] | |||
| | |||
* Abdominal [[Computed tomography|CT]] | |||
| | |||
* Abdominal [[Computed tomography|CT]] | |||
| | |||
* Serum [[cortisol]] testing | |||
* Serum [[ACTH]] testing | |||
* Anti-adrenal [[Antibody|Ab]] testing | |||
|- | |||
![[Menopause]] | |||
|Chronic | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |||
| | |||
* [[Hot flashes]] | |||
* [[Insomnia]] | |||
* [[Weight gain]] and [[bloating]] | |||
* Mood changes | |||
| | |||
* [[Vaginal atrophy]] | |||
* Loss of pelvic [[muscle tone]] | |||
| | |||
* ↑ [[FSH]] | |||
* ↓ [[Estradiol]] and [[inhibin]] | |||
| | |||
* [[FSH]] > [[LH]] | |||
|Normal | |||
| | |||
* [[Endometrial biopsy]] | |||
|} | |||
<small> | |||
==Treatment== | ==Treatment== |
Latest revision as of 19:44, 14 September 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S
Synonyms and keywords: Secondary hypoganadism; Central hypogonadism; gonadotropin-releasing hormone deficiency; gonadotropin deficiency; HH; primary HH, secondary HH; syndromic HH; isolated hypogonadotropic hypogonadism; primary hypogonadotropic hypogonadism
Overview
Hypogonadotropic hypogonadism is a condition which is characterized by hypogonadism due to an impaired secretion of gonadotropins, including follicle-stimulating hormone (FSH) and luteinizing hormone (LH), by the pituitary gland in the brain, and in turn decreased gonadotropin levels and a resultant lack of sex steroid production.[1]
Pathophysiology
The type of HH, based on its cause, may be classified as either primary or secondary.
Primary Hypogonadotropic Hypogonadism
Primary HH, also called isolated HH, is responsible for only a small subset of cases of HH, and is characterized by an otherwise normal function and anatomy of the hypothalamus and anterior pituitary. It is caused by congenital syndromes such as Kallmann syndrome and gonadotropin-releasing hormone (GnRH) insensitivity.
Secondary Hypogonadotropic Hypogonadism
Secondary HH, also known as acquired or syndromic HH, is far more common than primary HH, and is responsible for most cases of the condition. It has a multitude of different causes, including brain or pituitary tumors, pituitary apoplexy, head trauma, ingestion of certain drugs, and certain systemic diseases and syndromes.[1]
Diagnosis
Symptoms
Symptoms of hypogonadism include
Differentiating hypogonadism from other diseases:
Hypogonadotropic hypogonadism should be differentiated from other diseases causing hypogonadism like features.[2][3][4][5][6][7][8]
Diseases | Onset | Manifestations | Diagnosis | |||||||
---|---|---|---|---|---|---|---|---|---|---|
History and Symptoms | Physical examination | Laboratory findings | Gold standard | Imaging | Other investigation findings | |||||
Trumatic delivery | Lactation failure | Menstrual irregularities | Other features | |||||||
Sheehan's syndrome | Acute | ++ | ++ | Oligo/amenorrhea | Symptoms of: |
|
|
CT/MRI:
|
| |
Lymphocytic hypophysitis | Acute | +/- | + | Oligo/amenorrhea |
|
|
|
Assays for:
| ||
Pituitary apoplexy | Acute | +/- | ++ | Oligo/amenorrhea | Severe headache
|
|
|
Blood tests may be done to check: | ||
Empty sella syndrome | Chronic | - | + | Oligo/amenorrhea |
|
|
|
|
| |
Simmonds' disease/Pituitary cachexia | Chronic | +/- | + | Oligo/amenorrhea |
|
|
|
| ||
Hypothyroidism | Chronic | +/- | - | Oligomenorrhea/menorrhagia |
|
|
|
|
|
|
Hypogonadotropic hypogonadism | Chronic | - | - | Oligo/amenorrhea |
|
|
|
|
| |
Hypoprolactinemia | Chronic | - | + | - |
|
|
|
|
|
|
Panhypopituitarism | Chronic | - | + | Oligo/amenorrhea |
|
|
|
|
| |
Primary adrenal insufficiency/Addison's disease | Chronic | - | - | - |
|
|
|
| ||
Menopause | Chronic | - | +/- | Oligo/amenorrhea |
|
|
Normal |
Treatment
Treatment of HH may consist of administration of either a GnRH agonist or a gonadotropin formulation in the case of primary HH and treatment of the root cause (e.g., a tumor) of the symptoms in the case of secondary HH. Alternatively, hormone replacement therapy with androgens and estrogens in males and females, respectively, may be employed.
See also
- Hypogonadism
- Delayed puberty and infertility
- Hypothalamus, pituitary gland, and HPG axis
- Gonads (testicles and ovaries)
- GnRH and gonadotropins (FSH and LH)
- Sex hormones (androgens and estrogens)
References
- ↑ 1.0 1.1 "Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency Overview - GeneReviews™ - NCBI Bookshelf".
- ↑ Sato N, Sze G, Endo K (1998). "Hypophysitis: endocrinologic and dynamic MR findings". AJNR Am J Neuroradiol. 19 (3): 439–44. PMID 9541295.
- ↑ Powrie JK, Powell M, Ayers AB, Lowy C, Sönksen PH (1995). "Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature". Clin. Endocrinol. (Oxf). 42 (3): 315–22. PMID 7758238.
- ↑ Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S (2015). "Diagnosis of Primary Hypophysitis in Germany". J. Clin. Endocrinol. Metab. 100 (10): 3841–9. doi:10.1210/jc.2015-2152. PMID 26262437.
- ↑ Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S (1995). "Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings". J. Clin. Endocrinol. Metab. 80 (8): 2302–11. doi:10.1210/jcem.80.8.7629223. PMID 7629223.
- ↑ Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H (1993). "Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus". N. Engl. J. Med. 329 (10): 683–9. doi:10.1056/NEJM199309023291002. PMID 8345854.
- ↑ Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS (2011). "Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman". Emerg Med Australas. 23 (3): 372–5. doi:10.1111/j.1742-6723.2011.01425.x. PMID 21668725.
- ↑ Dejager S, Gerber S, Foubert L, Turpin G (1998). "Sheehan's syndrome: differential diagnosis in the acute phase". J. Intern. Med. 244 (3): 261–6. PMID 9747750.